Previous studies have mainly focused on AR as a type of nuclear receptor TF that has the ability to promote tumor growth and development by binding to downstream target genes and mediating the activation of genes related to proliferation, anti-apoptosis, or other cancer genes (Huang et al., 2018). Here, TF is linked to cancer.